The World’s First Animal-Free Insulin Assay
PCRM has developed a new insulin assay, which sidesteps controversial
animal-derived ingredients used in typical assays.
In January, PCRM’s Neal Barnard, M.D., launched an important
clinical trial to test the effect of a low-fat, vegan diet on patients
with type 2 diabetes. Early on, we discovered the lab test we needed
to measure insulin involved animal-derived antibodies. Rather than
support animal cruelty (the antibodies are grown in the painfully
swollen bodies of mice and rats), we decided to look for a lab that
could grow the antibodies in a test tube.
Unfortunately, labs that grow antibodies in test tubes typically
use fetal calf serum—a cruel byproduct of slaughterhouses—as
a growth promoter. After much searching, we finally found a lab
willing to attempt to develop an assay that didn’t depend
on fetal calf serum. The project took several months and was not
cheap, but we’re delighted to report the cells grew perfectly
well, and the antibodies work exactly like those used in traditional
tests. The new method will soon be used to analyze insulin levels
in our study participants’ blood samples.
For more information about this new insulin assay, please contact
research analyst Megha Even, M.S., at 202-686-2210, ext. 327, or
meven@pcrm.org.
Funded by the National Institutes of Health, PCRM’s diabetes
study is conducted in coordination with investigators from the George
Washington University and the University of Toronto.
PCRM Online,
July 2004
Media
Center | Health | Research
| About PCRM | Catalog
| Join Us | Search
| Site Index | Home
The site does
not provide medical or legal advice. This Web site is for information purposes
only.
Full Disclaimer | Privacy Policy
|